Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 2023 Jan 17;133(2):e167843. doi: 10.1172/JCI167843

Reprogramming dysfunctional CD8+ T cells to promote properties associated with natural HIV control

Federico Perdomo-Celis, Caroline Passaes, Valérie Monceaux, Stevenn Volant, Faroudy Boufassa, Pierre de Truchis, Morgane Marcou, Katia Bourdic, Laurence Weiss, Corinne Jung, Christine Bourgeois, Cécile Goujard, Laurence Meyer, Michaela Müller-Trutwin, Olivier Lambotte, Asier Sáez-Cirión
PMCID: PMC9843039  PMID: 36647831

Original citation: J Clin Invest. 2022;132(11):e157549. https://doi.org/10.1172/JCI157549

Citation for this corrigendum: J Clin Invest. 2023;133(2):e167843. https://doi.org/10.1172/JCI167843

In Figure 1E, the data for BCL-6 was inadvertently omitted, with a duplicate of the data for TOX shown on that line instead. The PDF and HTML versions have been updated, and the correct figure panel is below.

Figure 1E.

Figure 1E.

Open in a new tab

The authors regret the error.

Version 1. 01/17/2023

Electronic publication

Footnotes

Articles from The Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES